+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

An update on the management of young-onset Parkinson's disease



An update on the management of young-onset Parkinson's disease



Degenerative Neurological and Neuromuscular Disease 2: 53-62



In the text that follows, we review the main clinical features, genetic characteristics, and treatment options for Parkinson's disease (PD), considering the age at onset. The clinical variability between patients with PD points at the existence of subtypes of the disease. Identification of subtypes is important, since a focus on homogenous group may lead to tailored treatment strategies. One of the factors that determine variability of clinical features of PD is age of onset. Young-onset Parkinson's disease (YOPD) is defined as parkinsonism starting between the ages of 21 and 40. YOPD has a slower disease progression and a greater incidence and earlier appearance of levodopa-induced motor complications; namely, motor fluctuations and dyskinesias. Moreover, YOPD patients face a lifetime of a progressive disease with gradual worsening of quality of life and their expectations are different from those of their older counterparts. Knowing this, treatment plans and management of symptoms must be paid careful attention to in order to maintain an acceptable quality of life in YOPD patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066606961

Download citation: RISBibTeXText

PMID: 30890879

DOI: 10.2147/dnnd.s34251


Related references

Frequency of psychiatric disorders in young-onset Parkinson's disease does not differ from typical-onset Parkinson's disease. Parkinsonism and Related Disorders 15(2): 153-155, 2009

Quality of sleep in young onset Parkinson's disease: Any difference from older onset Parkinson's disease. Parkinsonism and Related Disorders 21(5): 461-464, 2015

An update on the management of juvenile and young-onset Parkinsons disease. Future Neurology 7(5): 581-593, 2012

Young onset Parkinson's disease. Practical management of medical issues. Parkinsonism and Related Disorders 14(2): 133-142, 2008

Comparing clinical features of young onset, middle onset and late onset Parkinson's disease. Parkinsonism and Related Disorders 20(5): 530-534, 2014

Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?. Journal of Neurology Neurosurgery and Psychiatry 83(3): 251-257, 2012

Old-onset Parkinson's disease compared with young-onset disease: Clinical differences and similarities. Acta Neurologica Scandinavica 89(4): 258-261, 1994

Is depression greater in young-onset or late-onset Parkinson's disease?. 2007

The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. Archives of Neurology 48(9): 903-907, 1991

Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's disease. Journal of Neurology 260(1): 131-137, 2013

Early onset Parkinson's disease: are juvenile- and young-onset different?. Movement Disorders 9(5): 539-544, 1994

A comparison of LEDD and motor scores following STN-DBS treatment in patient with young onset vs. late onset Parkinson's disease. Neuromodulation 13(4): 255-260, 2010

Association of N-acetyl transferase 2 gene polymorphism and slow acetylator phenotype with young onset and late onset Parkinson's disease among Indians. Pharmacogenetics and Genomics 15(10): 731-735, 2005

Young onset Parkinson's disease. Movement Disorders 2(2): 73-91, 1987

Cell therapy for Parkinson's disease: only young onset patients allowed? Reflections about the results of recent clinical trials with cell therapy and the progression of Parkinson's disease. Cell Transplantation 15(6): 463-473, 2006